IGI Laboratories, Inc. Announces 1st Quarter 2013 Results
4/26/2013 6:12:32 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the first quarter ended March 31, 2013.
First Quarter 2013 Highlights vs. 2012
•Total revenues of $3.7 million in the first quarter of 2013, an increase of 101% over the same quarter in 2012
Help employers find you! Check out all the jobs and post your resume.